Universe Pharmaceuticals (UPC) Equity Ratio (2020 - 2024)

Historic Equity Ratio for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to 809.91.

  • Universe Pharmaceuticals' Equity Ratio rose 12085063.09% to 809.91 in Q3 2025 from the same period last year, while for Sep 2025 it was 809.91, marking a year-over-year increase of 12085063.09%. This contributed to the annual value of 809.91 for FY2025, which is 12085063.09% up from last year.
  • Universe Pharmaceuticals' Equity Ratio amounted to 809.91 in Q3 2025, which was up 12085063.09% from 0.67 recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Equity Ratio ranged from a high of 809.91 in Q3 2025 and a low of 0.54 during Q1 2024
  • For the 5-year period, Universe Pharmaceuticals' Equity Ratio averaged around 259.63, with its median value being 0.76 (2021).
  • As far as peak fluctuations go, Universe Pharmaceuticals' Equity Ratio tumbled by 9999.99% in 2021, and later skyrocketed by 12085063.09% in 2025.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Equity Ratio stood at 0.67 in 2021, then skyrocketed by 88474.92% to 593.39 in 2022, then increased by 12.97% to 670.35 in 2023, then plummeted by 99.9% to 0.67 in 2024, then surged by 120850.63% to 809.91 in 2025.
  • Its Equity Ratio stands at 809.91 for Q3 2025, versus 0.67 for Q3 2024 and 0.54 for Q1 2024.